Willem
My mother has started on Vosaroxin trial that you mentioned below. It has 2 arms: control arm with cytarabine intermediate dose plus placebo and test arm with same cytarabine plus vosaroxin. Anyone who is participating is getting cytarabine intermediate dose and may or may not get the new drug.
Cytarabine intermediate dose is not the best approach to put someone in remission as there are some other agents (e.g., 7+3 or MEC protocol for when 7+3 didn't work). However, I guess because of my mom's age, intermediate dose of cytarabine would be the most she can handle, that is why trial was not a bad option for her.
She is 74. She is Russian but got sick in the US while visiting me. She may be a candidate for a transplant and had a consult; which raised some eyebrows when we mentioned to Russian doctors. Will see where this treatment takes us.
Good luck to you